Skip to main content
Clinical Trials/IRCT20210807052098N1
IRCT20210807052098N1Not yet recruitingPhase 4

Investigation of intravenous dexmedetomidine administration effect on patency of arteriovenous fistula in patients undergoing arteriovenous fistula creation surgery

Ghoum University of Medical Sciences0 sites50 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 80 years (—)
Sex
All

Inclusion Criteria

  • patients with renal failure and dependent on dialysis
  • candidate for arteriovenous fistula surgery
  • without heart failure
  • age below eighty years

Exclusion Criteria

  • The patient's unwillingness to participate in the study at any time during the study
  • Contraindications for the use of dexmedetomidine: severe heart block, severe bradycardia, severe heart failure, QT changes, hypotension, liver failure, intravascular volume depletion, allergy to alpha 2 agonists
  • age over 80 years
  • heart failure

Investigators

Sponsor
Ghoum University of Medical Sciences

Similar Trials